Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 2Squamous Intraepithelial Lesions 2Dyspareunia 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Dysplasia 1Papillomavirus Infections 1Ovarian Neoplasms 1HIV Infections 1Endometrial Neoplasms 1Breast Neoplasms 1Bowen's Disease 1Anus Neoplasms 1Acquired Immunodeficiency Syndrome 1

Interventions

Paclitaxel 95Carboplatin 77pembrolizumab 74Cisplatin 29Bevacizumab 27Surveys and Questionnaires 23Radiotherapy 22Letrozole 22Doxorubicin 21Megestrol Acetate 20olaparib 19lenvatinib 19Taxes 17Specimen Handling 17Docetaxel 17Nivolumab 16Magnetic Resonance Spectroscopy 16dostarlimab 15Metformin 15Blood Specimen Collection 14Observation 13Gemcitabine 13Biopsy 13durvalumab 12Medroxyprogesterone Acetate 12Trastuzumab 11Indocyanine Green 11Fulvestrant 11temsirolimus 10abemaciclib 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometrial Neoplasms × Laser Therapy × Gynecologic × Clear all
NCT03372720 2022-04-22

Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors

Ohio State University Comprehensive Cancer Center

Phase NA Completed
19 enrolled
Gynecologic

Uterine Cervical Neoplasms, Dyspareunia, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡